The molecular basis of X-linked deafness type 3 (DFN3) in two sporadic cases: identification of a somatic mosaicism for a POU3F4 missense mutation
- PMID:9298820
- DOI: 10.1002/(SICI)1098-1004(1997)10:3<207::AID-HUMU5>3.0.CO;2-F
The molecular basis of X-linked deafness type 3 (DFN3) in two sporadic cases: identification of a somatic mosaicism for a POU3F4 missense mutation
Abstract
We have investigated two unrelated males with X-linked deafness type 3 (DFN3) for mutations in the POU3F4 gene. In one patient, we observed a mutation that is predicted to result in an Arg330Ser amino acid substitution. In another DFN3 patient, a somatic mosaicism for an Arg323Gly amino acid substitution was found. This mosaicism was detected in two independently established EBV immortalized B cells and peripheral blood lymphocytes (PBLs). Semiquantitative analysis showed that approximately 50% of the PBLs of this patient carry the mutation. We hypothesize that the Arg323Gly mutation occurred very early in embryogenesis, before the differentiation of cells involved in hematopoiesis and inner ear development. In both patients, the missense mutations are situated in the POU homeodomain and are predicted to disrupt the DNA binding of the POU3F4 protein. All nine point mutations thus far described were found in the POU domains of POU3F4. Since these domains constitute only 35% of the open reading frame of POU3F4, there is a statistically significant preference for mutations in the POU-specific and POU homeodomain.
Similar articles
- Clinical and molecular characterizations of novel POU3F4 mutations reveal that DFN3 is due to null function of POU3F4 protein.Lee HK, Song MH, Kang M, Lee JT, Kong KA, Choi SJ, Lee KY, Venselaar H, Vriend G, Lee WS, Park HJ, Kwon TK, Bok J, Kim UK.Lee HK, et al.Physiol Genomics. 2009 Nov 6;39(3):195-201. doi: 10.1152/physiolgenomics.00100.2009. Epub 2009 Aug 11.Physiol Genomics. 2009.PMID:19671658
- Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4.de Kok YJ, van der Maarel SM, Bitner-Glindzicz M, Huber I, Monaco AP, Malcolm S, Pembrey ME, Ropers HH, Cremers FP.de Kok YJ, et al.Science. 1995 Feb 3;267(5198):685-8. doi: 10.1126/science.7839145.Science. 1995.PMID:7839145
- Clinical evaluation of DFN3 patients with deletions in the POU3F4 locus and detection of carrier female using MLPA.Song MH, Lee HK, Choi JY, Kim S, Bok J, Kim UK.Song MH, et al.Clin Genet. 2010 Dec;78(6):524-32. doi: 10.1111/j.1399-0004.2010.01426.x.Clin Genet. 2010.PMID:20412083
- Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM, Ito M, Naito E, Kuroda Y, Kerr DS, Wexler ID, Patel MS, Robinson BH, Seyda A.Lissens W, et al.Hum Mutat. 2000;15(3):209-19. doi: 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K.Hum Mutat. 2000.PMID:10679936Review.
- The ins and outs of X-linked deafness type 3.Cremers FP, Cremers CW, Ropers HH.Cremers FP, et al.Adv Otorhinolaryngol. 2000;56:184-95. doi: 10.1159/000059101.Adv Otorhinolaryngol. 2000.PMID:10868234Review.No abstract available.
Cited by
- A New Pathogenic Variant inPOU3F4 Causing Deafness Due to an Incomplete Partition of the Cochlea Paved the Way for Innovative Surgery.Tekin AM, Matulic M, Wuyts W, Assadi MZ, Mertens G, Rompaey VV, Li Y, Heyning PV, Topsakal V.Tekin AM, et al.Genes (Basel). 2021 Apr 21;12(5):613. doi: 10.3390/genes12050613.Genes (Basel). 2021.PMID:33919129Free PMC article.
- Considering gene therapy to protect from X-linked deafness DFNX2 and associated neurodevelopmental disorders.Defourny J.Defourny J.Ibrain. 2022 Sep 27;8(4):431-441. doi: 10.1002/ibra.12068. eCollection 2022 Winter.Ibrain. 2022.PMID:37786584Free PMC article.Review.
- A rapid improved multiplex ligation detection reaction method for the identification of gene mutations in hereditary hearing loss.Liu Y, Hu C, Liu C, Liu D, Mei L, He C, Jiang L, Wu H, Chen H, Feng Y.Liu Y, et al.PLoS One. 2019 Apr 11;14(4):e0215212. doi: 10.1371/journal.pone.0215212. eCollection 2019.PLoS One. 2019.PMID:30973918Free PMC article.
- Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review.Bernardinelli E, Huber F, Roesch S, Dossena S.Bernardinelli E, et al.Biomedicines. 2023 Jun 12;11(6):1695. doi: 10.3390/biomedicines11061695.Biomedicines. 2023.PMID:37371790Free PMC article.Review.
- APOU3F4 Mutation Causes Nonsyndromic Hearing Loss in a Chinese X-linked Recessive Family.Du W, Han MK, Wang DY, Han B, Zong L, Lan L, Yang J, Shen Q, Xie LY, Yu L, Guan J, Wang QJ.Du W, et al.Chin Med J (Engl). 2017 Jan 5;130(1):88-92. doi: 10.4103/0366-6999.196565.Chin Med J (Engl). 2017.PMID:28051029Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases